Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 2023-11-22 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 2024-06-13 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 2020-12-31 | |
| Chairman | 70 | 2020-12-31 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| +0.56% | -3.38% | -1.83% | +8.00% | 45.63B | |
| -0.12% | -1.19% | +343.42% | +545.03% | 43.96B | |
| +1.51% | +4.04% | +45.01% | +27.38% | 43.73B | |
| -2.07% | -1.42% | +4.28% | +72.97% | 40.23B | |
| -0.73% | -3.06% | +9.63% | +38.92% | 31.86B | |
| -9.49% | -11.23% | - | - | 17.4B | |
| +4.21% | +5.01% | +24.99% | +121.62% | 16.62B | |
| +1.83% | +3.20% | +16.49% | +32.73% | 14.46B | |
| -0.08% | -2.81% | +79.24% | +31.27% | 13.04B | |
| Average | -0.14% | -1.20% | +65.15% | +109.74% | 29.66B | |
| Weighted average by Cap. | -0.34% | -1.26% | +76.74% | +130.65% |
Employees
4
